HOME >> BIOLOGY >> NEWS
NIH awards millions to Rutgers for genetics research

NEW BRUNSWICK/PISCATAWAY, N.J. Rutgers will be home to a new genetics resource for scientists worldwide intent on solving the hereditary puzzles at the core of such diseases as diabetes, inflammatory bowel disease and kidney disorders. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a unit of the National Institutes of Health (NIH), has awarded a five-year, $9.3 million contract to the university to create the genetic repository.

"To date, no such resource has been available to researchers interested in studying genetics of the many diseases that NIDDK investigates," said Jay Tischfield, Duncan and Nancy MacMillan Professor of Genetics, and chair of the department of genetics at Rutgers, The State University of New Jersey. "Rutgers' repository will now enable investigators around the world to conduct population and family-based research on the genetic bases of these painful and debilitating afflictions."

The Rutgers University Cell and DNA Repository (RUCDR), of which Tischfield is scientific director, will collect, maintain and distribute cell lines and DNA for the NIDDK from human populations worldwide. Consistent with NIH initiatives that mandate the sharing of human biomaterials and research data, the new repository will provide researchers opportunities to collaborate internationally and study common pools of subjects to find genes that predispose individuals to such diseases.

The NIDDK award comes rapidly on the heels of a $22.6 million cooperative agreement award to Rutgers from the National Institute of Mental Health (NIMH) for a similar project in support of research into the genetics of mental disorders. Rutgers is now the genetic repository and resource for four NIH institutes: NIMH, NIDDK, the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The NIDA contract provides $8 million to Rutgers and the NIAAA, $5 million to Rutgers.

T
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
9-Jul-2003


Page: 1 2

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
3. NSF awards 22 new projects for plant genome research
4. The American Phytopathological Society announces 2004 awards
5. NSF announces six FIBR awards to tackle some of biologys most challenging questions
6. Two Virginia Tech energy-related inventions win R&D 100 awards
7. APS awards more than $140,000 to minority students of physiology
8. APS awards more than $36,000 to its 2004 undergraduate research fellows
9. 8 environmental stewards win $900,000 in biodiversity awards
10. UCSB professor and director receives two national awards
11. NSF awards $10 million in grants to ocean sites for long-term ecological research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH awards millions Rutgers for genetics research

(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
(Date:7/1/2015)... N.C. and PARIS ... firm AgBiome, and Genective, key developer of biotech ... the discovery of new generations of insect control ... insect control to counter the realities of advancing ... Genective, aligning AgBiome,s unique insect control technology with ...
(Date:7/1/2015)... ... 01, 2015 , ... The next-generation sequencing (NGS) clinical market is poised for ... diagnostics industry. BCC Research reveals in its new report that the market drivers of ... a growing need for better diagnostics as part of a molecular diagnostics trend. , ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
(Date:7/1/2015)... July 1, 2015 Isagenix International, a leading ... three Gold, three Silver, and three Bronze Stevie® Awards ... in Chicago this month.The ... business awards program in the U.S. ... strength in developing leaders, cultivating talent, creating a unified ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
Cached News: